BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 30808442)

  • 1. Paediatric haemolytic uraemic syndrome related to Shiga toxin-producing
    Bruyand M; Mariani-Kurkdjian P; Le Hello S; King LA; Van Cauteren D; Lefevre S; Gouali M; Jourdan-da Silva N; Mailles A; Donguy MP; Loukiadis E; Sergentet-Thevenot D; Loirat C; Bonacorsi S; Weill FX; De Valk H;
    Euro Surveill; 2019 Feb; 24(8):. PubMed ID: 30808442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemolytic uraemic syndrome and Shiga toxin-producing Escherichia coli infection in children in France. The Société de Néphrologie Pédiatrique.
    Decludt B; Bouvet P; Mariani-Kurkdjian P; Grimont F; Grimont PA; Hubert B; Loirat C
    Epidemiol Infect; 2000 Apr; 124(2):215-20. PubMed ID: 10813145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surveillance of hemolytic uremic syndrome in children less than 15 years of age, a system to monitor O157 and non-O157 Shiga toxin-producing Escherichia coli infections in France, 1996-2006.
    Espié E; Grimont F; Mariani-Kurkdjian P; Bouvet P; Haeghebaert S; Filliol I; Loirat C; Decludt B; Minh NN; Vaillant V; de Valk H
    Pediatr Infect Dis J; 2008 Jul; 27(7):595-601. PubMed ID: 18520972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemolytic uremic syndrome due to Shiga toxin-producing Escherichia coli infection.
    Bruyand M; Mariani-Kurkdjian P; Gouali M; de Valk H; King LA; Le Hello S; Bonacorsi S; Loirat C
    Med Mal Infect; 2018 May; 48(3):167-174. PubMed ID: 29054297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Community-wide outbreak of haemolytic uraemic syndrome associated with Shiga toxin 2-producing Escherichia coli O26:H11 in southern Italy, summer 2013.
    Germinario C; Caprioli A; Giordano M; Chironna M; Gallone MS; Tafuri S; Minelli F; Maugliani A; Michelacci V; Santangelo L; Mongelli O; Montagna C; Scavia G;
    Euro Surveill; 2016 Sep; 21(38):. PubMed ID: 27684204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody response to lipopolysaccharides and recombinant proteins of Shiga toxin (STX)-producing Escherichia coli (STEC) in children with haemolytic uraemic syndrome in Poland.
    Rastawicki W; Śmietańska K; Rokosz-Chudziak N; Wołkowicz T
    Lett Appl Microbiol; 2020 Jun; 70(6):440-446. PubMed ID: 32270510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outbreak of Shiga toxin-producing
    Jones G; Lefèvre S; Donguy MP; Nisavanh A; Terpant G; Fougère E; Vaissière E; Guinard A; Mailles A; de Valk H; Fila M; Tanné C; Le Borgne C; Weill FX; Bonacorsi S; Jourdan-Da Silva N; Mariani-Kurkdjian P
    Euro Surveill; 2019 May; 24(22):. PubMed ID: 31164190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating true incidence of O157 and non-O157 Shiga toxin-producing Escherichia coli illness in Germany based on notification data of haemolytic uraemic syndrome.
    Kuehne A; Bouwknegt M; Havelaar A; Gilsdorf A; Hoyer P; Stark K; Werber D;
    Epidemiol Infect; 2016 Nov; 144(15):3305-3315. PubMed ID: 27468812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outbreak of hemolytic uremic syndrome with unusually severe clinical presentation caused by Shiga toxin-producing Escherichia coli O26:H11 in France.
    Minary K; Tanne C; Kwon T; Faudeux C; Clave S; Langevin L; Pietrement C; Enoch C; Parmentier C; Mariani-Kurkdjian P; Weill FX; Jones G; Djouadi N; Morin D; Fila M
    Arch Pediatr; 2022 Aug; 29(6):448-452. PubMed ID: 35662540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterisation of human Shiga toxin-producing
    Usein CR; Ciontea AS; Militaru CM; Condei M; Dinu S; Oprea M; Cristea D; Michelacci V; Scavia G; Zota LC; Zaharia A; Morabito S
    Euro Surveill; 2017 Nov; 22(47):. PubMed ID: 29183554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and etiology of hemolytic-uremic syndrome in children in Norway, 1999-2008--a retrospective study of hospital records to assess the sensitivity of surveillance.
    Jenssen GR; Hovland E; Bjerre A; Bangstad HJ; Nygard K; Vold L
    BMC Infect Dis; 2014 May; 14():265. PubMed ID: 24884396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infections in pediatric postdiarrheal hemolytic uremic syndrome: factors associated with identifying shiga toxin-producing Escherichia coli.
    Mody RK; Luna-Gierke RE; Jones TF; Comstock N; Hurd S; Scheftel J; Lathrop S; Smith G; Palmer A; Strockbine N; Talkington D; Mahon BE; Hoekstra RM; Griffin PM
    Arch Pediatr Adolesc Med; 2012 Oct; 166(10):902-9. PubMed ID: 22869280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shiga toxin-producing escherichia coli infections in Norway, 1992-2012: characterization of isolates and identification of risk factors for haemolytic uremic syndrome.
    Brandal LT; Wester AL; Lange H; Løbersli I; Lindstedt BA; Vold L; Kapperud G
    BMC Infect Dis; 2015 Aug; 15():324. PubMed ID: 26259588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desperately seeking diarrhoea: outbreak of haemolytic uraemic syndrome caused by emerging sorbitol-fermenting shiga toxin-producing Escherichia coli O157:H-, Germany, 2009.
    Nielsen S; Frank C; Fruth A; Spode A; Prager R; Graff A; Plenge-Bönig A; Loos S; Lütgehetmann M; Kemper MJ; Müller-Wiefel DE; Werber D
    Zoonoses Public Health; 2011 Dec; 58(8):567-72. PubMed ID: 21824358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nationwide study of haemolytic uraemic syndrome: clinical, microbiological, and epidemiological features.
    Elliott EJ; Robins-Browne RM; O'Loughlin EV; Bennett-Wood V; Bourke J; Henning P; Hogg GG; Knight J; Powell H; Redmond D;
    Arch Dis Child; 2001 Aug; 85(2):125-31. PubMed ID: 11466187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Petting zoos as sources of Shiga toxin-producing Escherichia coli (STEC) infections.
    Schlager S; Lepuschitz S; Ruppitsch W; Ableitner O; Pietzka A; Neubauer S; Stöger A; Lassnig H; Mikula C; Springer B; Allerberger F
    Int J Med Microbiol; 2018 Oct; 308(7):927-932. PubMed ID: 30257809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased recognition of non-O157 Shiga toxin-producing Escherichia coli infections in the United States during 2000-2010: epidemiologic features and comparison with E. coli O157 infections.
    Gould LH; Mody RK; Ong KL; Clogher P; Cronquist AB; Garman KN; Lathrop S; Medus C; Spina NL; Webb TH; White PL; Wymore K; Gierke RE; Mahon BE; Griffin PM;
    Foodborne Pathog Dis; 2013 May; 10(5):453-60. PubMed ID: 23560425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Escherichia coli (STEC) serotype O104 outbreak causing haemolytic syndrome (HUS) in Germany and France.
    Rubino S; Cappuccinelli P; Kelvin DJ
    J Infect Dev Ctries; 2011 Jul; 5(6):437-40. PubMed ID: 21727641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An epidemiologic surveillance of Shiga-like toxin-producing Escherichia coli infection in Argentinean children: risk factors and serum Shiga-like toxin 2 values.
    López EL; Contrini MM; Glatstein E; Ayala SG; Santoro R; Ezcurra G; Teplitz E; Matsumoto Y; Sato H; Sakai K; Katsuura Y; Hoshide S; Morita T; Harning R; Brookman S
    Pediatr Infect Dis J; 2012 Jan; 31(1):20-4. PubMed ID: 21829137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shiga Toxin-Producing
    Bai X; Mernelius S; Jernberg C; Einemo IM; Monecke S; Ehricht R; Löfgren S; Matussek A
    Front Cell Infect Microbiol; 2018; 8():125. PubMed ID: 29765909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.